Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist

PURPOSE OF REVIEW: To provide neurologists with an update on the proposed mechanisms of action (MOAs) of disease-modifying therapies (DMTs) for the treatment of relapsing MS, and their effect on peripheral blood leukocytes, in order to inform treatment decisions. RECENT FINDINGS: DMTs have vastly di...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Edward J., Buckle, Guy J., Singer, Barry, Singh, Vibhuti, Boster, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382377/
https://www.ncbi.nlm.nih.gov/pubmed/30859008
http://dx.doi.org/10.1212/CPJ.0000000000000567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382377/
https://www.ncbi.nlm.nih.gov/pubmed/30859008
http://dx.doi.org/10.1212/CPJ.0000000000000567

Ejemplares similares